 prospective trial adjuvant chemotherapy bolus versus continuous infusion doxorubicin patients high-grade extremity soft tissue sarcoma analysis prognostic factors prospective trial cardiotoxic therapeutic effects doxorubicin weeks bolus continuous infusion adjuvant chemotherapy eligible patients resection high-grade soft tissue sarcoma extremity superficial trunk Cardiac toxicity decrease left ventricular ejection fraction radionuclide cineangiography patients Cardiotoxicity patients bolus treatment arm median doxorubicin dose patients continuous infusion cardiotoxicity median dose rate cardiotoxicity function cumulative dose doxorubicin bolus treatment arm patients group clinical congestive heart failure cardiac death trend rate metastasis rate death disease patients bolus dose Cox model analysis unfavorable characteristics rate distant metastasis blood transfusion hours operation deep fascia cm size histologic subtype liposarcoma unfavorable effect continuous infusion model Adjuvant chemotherapy patients soft tissue sarcoma investigational impact perioperative blood transfusion study